论文信息 - KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC - 字舞流文

KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC

Changli Wang | I. Vynnychenko | V. Sriuranpong | Cheng Huang | S. Ren | Caicun Zhou | Kai Wang | Jianying Zhou | F. Orlandi | Jifeng Feng | J. Ge | Ben Li | Jianxing He | T. Dang | Sheng-gao Ma | Hua-jun Chen | Zhiyong Ma | Li Zhang | Chin-Chou Wang | P. Danchaivijtr